Can i take prednisone for my cough -
Looking for:
- Coughing Sucks! What Can You Do To Treat Bronchitis? | Cirrus Medical Network- Prednisone works well for range of conditions, but can have many side effects - localhost
Story by: Menisa Marshall on September 19, I was awake and coughing my head off. It felt like a giant hair ball was stuck in my lungs, but no amount of hacking would dislodge it. The good news is I had no body aches or fever. The bad news is I knew I faced two to three weeks of constant coughing and sleepless nights. It was bronchitis. She was surprised to be prescribed steroids — a first for her that raised some concerns given the negative things you hear about them. But they worked well and her coughing improved dramatically by the next day.
According to James Jennings, M. Jennings said. Fortunately, my recent bronchitis saga took a happy turn thanks in part to steroids. By that Saturday morning I was being seen by a physician who assessed my breathing, temperature, history and other key medical indicators.
The diagnosis, as expected, was allergy-induced bronchitis. We talked about treatment options and outcomes. I left with prescriptions for a one-week supply of corticosteroids prednisone , a two-week supply of allergy medicine and codeine cough syrup a virtual lifesaver! I got the medications on the way home and began taking them that day. By Sunday afternoon I was doing measurably better. By Monday, I was at work with very little coughing.
The biggest takeaway from my experience is not to make assumptions about your medical care and what you think you know. How can you know what care options are available unless you seek professional medical help? If you need medical care, visit one of 13 convenient Norton Immediate Care Centers. Most are open seven days a week, 9 a. Are they safe for bronchitis, asthma, arthritis?
Late on a recent Friday evening I felt a bit congested, and my throat had a familiar tickle. In broad terms, there are three things people should understand about steroids: There is a marked difference between anabolic steroids and corticosteroids. Anabolic steroids include testosterone and synthetic lab made substances that mimic testosterone.
Corticosteroids are anti-inflammatory medications prescribed by physicians as medical treatment for a variety of conditions. Corticosteroids can have many side effects that can range from mild to serious. Common side effects may include weight gain or swelling, puffy face, headache, muscle weakness, poor diabetes control, glaucoma and cataracts.
Potential side effects from corticosteroids are typically more apparent when they are used at higher doses or for extended periods of time. These powerful medications should always be used as directed by a physician. Schedule an Appointment Select an appointment date and time from available spots listed below.
❿3 things you should know about steroids | Norton Healthcare Louisville, Ky..Cough variant asthma: usefulness of a diagnostic-therapeutic trial with prednisone
Cough variant asthma is characterized as a persistent, nonproductive cough with minimal or no wheezing and dyspnea.
The diagnosis can be overlooked or misdisagnosed. We describe the severity of cough, the misery of some patients who have this syndrome and the usefulness of a diagnostic-therapeutic trial in ten patients with cough variant asthma.
We evaluated ten patients whose chief complaint was persistent nonproductive cough. During the course of evaluation, all patients received a diagnostic-therapeutic trial of prednisone for cough variant asthma after other major causes of cough had been excluded. The duration of cough ranged from 2 months to 20 years. Some patients had significant side effects from coughing including interference with social life, work and sleep, urinary incontinence, stool incontinence, hoarseness, and vomiting.
After a diagnostic-therapeutic trial with prednisone, nine patients reported significant improvement of cough in three days. One patient required 2 weeks of therapy for optimal improvement. All were subsequently controlled primarily with inhaled conticosteroids. The diagnosis of cough variant asthma may not be made for a prolonged time. A short course of prednisone as a diagnostic-therapeutic trial can establish a diagnosis and be followed by an effective method of control of cough by inhaled corticosteroids.
Abstract Cough variant asthma is characterized as a persistent, nonproductive cough with minimal or no wheezing and dyspnea. Gov't Research Support, U. Gov't, P. Substances Prednisone.
❾-50%}.
One patient required 2 weeks of therapy for optimal improvement. All were subsequently controlled primarily with inhaled conticosteroids. The diagnosis of cough variant asthma may not be made for a prolonged time.
A short course of prednisone as a diagnostic-therapeutic trial can establish a diagnosis and be followed by an effective method of control of cough by inhaled corticosteroids. Most are open seven days a week, 9 a.
Are they safe for bronchitis, asthma, arthritis? Late on a recent Friday evening I felt a bit congested, and my throat had a familiar tickle. In broad terms, there are three things people should understand about steroids: There is a marked difference between anabolic steroids and corticosteroids.
Anabolic steroids include testosterone and synthetic lab made substances that mimic testosterone. Corticosteroids are anti-inflammatory medications prescribed by physicians as medical treatment for a variety of conditions.
Corticosteroids can have many side effects that can range from mild to serious. Common side effects may include weight gain or swelling, puffy face, headache, muscle weakness, poor diabetes control, glaucoma and cataracts. Often, a patient's first introduction to prednisone is when a child or adult has a severe upper respiratory infection, asthma or pneumonia. He has found that parents are often upset because children can have dramatic reactions to it.
If they are already somewhat hyperactive, their behavior can become worse, Craven said. So he tells parents of that possibility upfront. If a patient -- a child or adult -- takes prednisone for more than a few weeks or months, the side effects can be far more serious. Taking the drug long-term, as, for example, people with MS or lupus might, increases the risk of cataracts and, more commonly, of bone loss.
Diminished bone density and osteoporosis are well-known complications of oral prednisone treatment. A study of injected corticosteroids found that a single shot into the spine for back pain reduced bone mineral density of the hip. Whether administered by injection, in pills or through an inhaler, steroids weaken bones. So, doctors often advise patients on prednisone to take extra vitamin D and calcium; osteoporosis medications may even be prescribed to prevent fractures. They also recommend that people take prednisone with food or milk to limit stomach discomfort.
Because of prednisone's side effects, doctors often prescribe it in a step-down dosage -- a blast of higher doses at the beginning, then tapering off. Prednisone suppresses the immune system and adrenal function, so doctors say that if you stop cold turkey, the adrenal glands may not respond as they would normally. Effect of oral prednisolone on symptom duration and severity in nonasthmatic adults with acute lower respiratory tract infection: a randomized clinical trial.
Effect of oral dexamethasone without immediate antibiotics vs placebo on acute sore throat in adults: a randomized clinical trial. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Pharmacokinetics of prednisone in normal and asthmatic subjects in relation to dose. Eur J Clin Pharmacol. Recommendations for the management of cough in adults. Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis. PLoS One. Ward N. The Leicester Cough Questionnaire. J Physiother. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire LCQ.
Health Qual Life Outcomes. Accessed 19 Oct What is the minimal important difference for the Leicester Cough Questionnaire? Pharmacology and therapeutics of cough. Berlin: Springer; Chapter Google Scholar. Montelukast for postinfectious cough in adults: a double-blind randomized placebo-controlled trial.
Lancet Respir Med. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. Statement on the second meeting of the International Health Regulations emergency committee regarding the outbreak of novel coronavirus nCoV. Geneva: WHO; Accessed 17 Jun Google Scholar. Clinical features of patients infected with novel coronavirus in Wuhan, China. International council for harmonisation of technical requirements for pharmaceuticals for human use ICH.
Accessed 28 May International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use.
Statistical principles for clinical trials, E9, Step 4. ICH harmonized tripartite guideline. Adult current smoking: differences in definitions and prevalence estimates. J Environ Public Health. Per-protocol analyses of pragmatic trials. N Engl J Med. European Medicines Agency. Accessed 27 May Mice: multivariate imputation by chained equations in R.
J Stat Softw. Common terminology criteria for adverse events. Ann Intern Med. Better reporting of interventions: template for intervention description and replication TIDieR checklist and guide. BMC Med. Cough: a worldwide problem. Otolaryngol Clin N Am.
International Committee of Medical Journal Editors. Defining the role of authors and contributors. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, National Center for Health Statistics.
Vital Health Stat. Birrig SS. Developing antitussives: the ideal clinical trial. Pulm Pharmacol Ther. German Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic cough.
Respir Med. Voelker R. Boxed warning for allergy drug. PubMed Google Scholar. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.
Effectiveness of a chronic cough management algorithm at the transitional stage from acute to chronic cough in children: a multicenter, nested, single-blind, randomised controlled trial.
Lancet Child Adolesc Health ;3 12 :P— Thornton J. Clinical trials suspended in UK to prioritize covid studies and free up staff. Spinou A, Birring SS. An update on measurement and monitoring of cough: what are the important study endpoints? J Thorac Dis.
Download references. The authors would like to acknowledge the helpful comments and suggestions provided by the anonymous SNSF reviewers. Their input led to the improvement of the study proposal and scientific quality. We would also like to recognize the support of Prof.
Professor Hay has shared the broad experience of his working group in infection research in community and primary care with the OSPIC investigators. The authors thank him for the methodological comments he made to the proposal and express appreciation for his guidance as an external expert to the study.
The CTU and the Pharmacy Department at the University Hospital Basel are acknowledged for their guidance and collaboration on study design, regulatory approvals and research implementation. CM is a Co-Investigator; he contributed to the conception and study design and supported the proposal. SE is a Co-Investigator; he contributed to the conception and study design.
DOBB is the Project Manager; she contributed to study design and supports the project development and implementation. JDL is a Co-Investigator; he contributed to the conception and study design and supported the proposal. BS contributed to the study design and methodology. TEE provided statistical support for study design and methodology.
LGH is the lead trial methodologist and contributed to study design. AZ is the Sponsor-Investigator; he conceived the study design, led the proposal and protocol development and is responsible for project development and implementation. All authors contributed to the refinement of the study protocol and read and approved the final manuscript.
For the main publication of the trial, authorship will be determined at study research meetings according to contribution to the project, i. AZ and CM will write the draft of the manuscript that will be comprehensively reviewed by a native English-speaking person. The funder does not have a role in the design and conduct of the study, collection, management, analysis and interpretation of data.
The study is also supported by Prof. The Centre for Primary Health Care has its offices in the Cantonal Hospital Baselland and will act as the coordinating centre for the conduct of the study. The Centre uniham-bb has office and infrastructure for a total of 5 researchers as well as storage facilities according to Swissmedic requirements.
Storage facilities can be accessed and used throughout the trial. All collaborating investigators mentioned above support this project and make substantial non-financial contributions. The CTU at the University Hospital Basel is supporting the study by providing monitoring, data management and statistical services.
The study is also supported by the Pharmacy department of the University Hospital Basel. The Pharmacy department is in charge of the study medication packaging and labelling, as well as managing the pharmaceutical documentation for the regulatory authorization from Swissmedic. The CDMA will be locked after data entry is completed; all data has been monitored and raised queries have been resolved.
Trials volume 21Article number: Cite this article. Metrics details. Cough is a common reason for patients to visit general practices. It can be disabling in daily activities, with substantial impact on physical and psychosocial health, leading to impaired quality of life and increased health care costs.
Recommendations for the management of post-infectious cough in primary care are scarce and incoherent. A systematic review and meta-analysis of randomized clinical trials RCT assessing patient-relevant benefits and potential harms of available treatments identified six eligible RCTs assessing different treatment regimens i. No RCT found clear patient-relevant benefits and most had an unclear or high risk of bias.
Post-infectious cough is thought to be mediated by inflammatory processes that are also present in exacerbations of asthma or chronic obstructive pulmonary diseases for which there is strong evidence that oral corticosteroids provide patient-relevant benefit without relevant harm. We therefore plan to conduct the first RCT evaluating the effectiveness of oral corticosteroids for post-infectious cough. We are conducting a triple-blinded randomized-controlled and multicentred superiority trial in primary health care practices in Switzerland.
Participants will be randomly allocated to either the 5-day treatment with oral corticosteroids or placebo. Secondary outcomes include cough-related quality of life at several time points, overall cessation of cough and adverse events. This RCT will provide evidence on whether oral corticosteroids are beneficial and safe in patients with post-infectious cough.
Results can have a substantial impact on the well-being and management of these patients in Switzerland and beyond. An evidence-based treatment for this condition may reduce re-consultations with GPs and spending for antitussive drugs, thus possibly having an impact on health care spending.
Prospectively registered on 18 January Peer Review reports. Cough as a symptom of respiratory infections is frequent in primary care and is one of the most common causes to seek medical advice in general practices GP [ 1 ].
Cough after an upper respiratory tract infection can be very bothersome and disabling in daily activities and has a significant impact on physical and psycho-social health, leading to impairment in quality of life QoL [ 2 ].
Recommendations for the management of post-infectious cough in general practice are scarce and inconsistent [ 34 ]. A previous systematic review and meta-analysis of randomized controlled trials RCT carried by our group provided a wide overview of treatment options for primary care patients with post-infectious cough and examined the patient-relevant benefits and potential harms of available therapies [ 7 ].
The review found only six RCTs assessing diverse treatment regimens, such as inhaled fluticasone propionate, inhaled budesonide, salbutamol plus ipratropium-bromide, montelukast, nociception-opioidreceptor agonist, codeine and gelatine.
Most of the studies included in the review had an unclear or high risk of bias [ 7 ]. Two RCTs assessed inhaled corticosteroids for post-infectious cough [ 89 ]. Pornsuriyasak et al. The trial by Ponsioen et al. Clinical guidelines and recommendations on the use of inhaled corticosteroids are unclear [ 3410 ].
A Cochrane review published in evaluated studies in which inhaled corticosteroids were tested in individuals with post-infectious or chronic cough [ 11 ]. A majority of the studies focused on patients with chronic cough and only two examined the benefits for post-infectious cough [ 11 ]. The authors concluded that no recommendation can be proposed due to the high heterogeneity and inconsistency of the studies and their results [ 11 ].
Additionally, an RCT in family practices in England found no benefit in terms of duration or severity of cough after a 5-day treatment with oral corticosteroids compared to placebo for adult patients with acute lower respiratory tract infection and without asthma [ 12 ]. Another RCT assessed the effectiveness of oral corticosteroids for patients with acute sore throat, Many of the symptoms in post-infectious cough are thought to be mediated by inflammatory processes that are also present in exacerbations of asthma or COPD [ 56 ].
However, at present, there is no established evidence-based treatment option for post-infectious cough, despite it being a very frequent condition. There is also considerable uncertainty regarding patient benefits from using inhaled or oral corticosteroids. The systematic search of our group did not identify any published RCT that assessed short-term use of oral corticosteroids for post-infectious cough [ 7 ] we updated our search in October and still found no pertinent trial.
We screened multiple study registries using the International Clinical Trials Registry Platform from the World Health Organization last search June and again found no trial investigating the use of oral corticosteroids for post-infectious cough. A well-conducted randomized placebo-controlled trial is needed to determine the benefits and harms of using oral corticosteroids to treat post-infectious cough in patients in primary care.
This randomized placebo-controlled trial aims to assess whether the benefits and harms of a 5-day prednisone treatment differ from those of a 5-day course of placebo. We designed a protocol for a randomized, parallel-group, placebo-controlled, triple-blinded, multicentred superiority trial in a primary health care setting, with blinded patients, physicians and outcome assessors.
Patients with post-infectious cough will be recruited by participating doctors in primary practices from cantons in the German-speaking part of Switzerland. Patient recruitment will continue until the sample size is reached. A list of the general practices currently taking part in the study can be obtained from the Sponsor-Investigator. Known or suspected diagnoses associated with cough, such as pneumonia, allergic rhinitis, sinusitis, bronchial asthma, COPD, gastroesophageal reflux disease.
Other chronic diseases such as bronchiectasis, cystic fibrosis, cancer, tuberculosis, heart failure. Regular treatment known to be associated with cough e. Uncontrolled diabetes mellitus as deemed by GPs who appraise whether the potential side effects of short-time corticosteroids on glucose levels exceed the hypothesized benefit on cough. Patients with post-infectious cough presenting to their GP will be told about the OSPIC trial and provided with a study leaflet, participant information sheet and a consent form by their GP.
They will be invited by the GP to take part after being given full written and verbal explanations of the trial purpose, potential benefits and risks and the procedures involved. Those who agree to join the study will be asked to provide written consent and will be screened against the full eligibility criteria described above.
Participants will have sufficient time to ask questions and GPs will make sure to underscore that participation is voluntary and that declining to join the study does not influence in any way the standard of care provided to patients.
During the informed consent process with the GP, participants will be asked to give written permission for the storage and future use of the data resulted from the study.
Placebo pills are described in detail in the next section. Placebo will be used as a comparator in this study to prevent various biases in particular as the primary endpoint is patient-reported. Potential implications on a limited applicability of the results are acknowledged and will be discussed in the study results publication.
From an ethical point of view, an inactive control placebo seems justified since there is no established therapy for post-infectious cough and because the symptoms resolve over time due to the natural course of the disease [ 712 ]. The placebo tablets match in appearance, diameter and height the intervention medication. Verbal and written instructions on how the drugs should be taken will be provided to the study participants. Even though the likelihood is very low, adverse events AEsuch as allergic reactions to the study drug, psychotic or pre-psychotic episode, or serious adverse events SAEsepsis, venous thromboembolism, fracture, can occur [ 17 ].
In any of these cases, the treatment will be stopped immediately. Medication will also be discontinued for other urgent reasons, such as pregnancy, a cancer diagnosis or an infection other than an upper respiratory tract infection. In order to facilitate adherence to the study intake schedule, participants are given a written medication guide. GPs will inform patients in depth on the importance to adhere to the 5-day medication for ensuring the effectiveness of treatment. Furthermore, the dosing schedule is very convenient as the drugs need to be taken only once a day during breakfast and for a clearly defined and limited timeframe.
In the event of a missed dose, patients are instructed to continue to take the medication the next day. Adherence to the study procedures will be checked at the follow-up phone call on day 7 from randomization when research staff will ask participants about their medication intake. In case the study medication is prematurely stopped or discontinued patients are asked to return the empty drug glass jars to their GP.
Apart from the use of corticosteroids, any co-treatment or co-medication i. Any other medical intervention used by study participants will be recorded in the electronic Case Report Forms eCRF to analyse the potential influence on outcomes. Treating doctors can independently decide to change to open-label treatment, adjust medication if they deem it necessary and for the benefit of their patients or choose additional therapeutic options.
All participants will be asked at follow-up about concurrent medication, including if they started a treatment with antibiotics. GPs and research staff are instructed to document time of onset, duration, resolution, actions to be taken, assessment of intensity and relationship with study treatment. Participants will be advised that they need to use contraceptives for the duration of the treatment and that they should inform the GP or the study team in case they suspect they have become pregnant.
Women with anamnestic risk of a pregnancy unprotected sexual intercourse in the last 2 weeks shall be excluded from this study. If a participant will become pregnant during follow-up, the participant will visit her gynaecologist. The GP will document the course and the outcome of the pregnancy. Total and individual LCQ domain scores will be calculated. The LCQ is also suitable for capturing longitudinal developments in cough and cough-related well-being and can be useful in clinical trials assessing new medications for cough [ 20 ].
Appointments for the next phone calls will be set during the previous phone call and will assess:. Changes in glucose levels for patients with pre-study controlled diabetes that are deemed by GP to exceed the hypothesized benefit on cough. Continuous outcomes will be assessed by comparing mean values. Medians will be considered in addition if we identify severe departures from normal distribution. Eligible patients who consent to the study will be randomly assigned by their GP to the active treatment or the control group.
If performed, the GP will also record diagnostic test results. Participants will be asked to complete the standardized LCQ questionnaire and hand it to the GP on day 0. Participants will also be informed about the follow-up calls and that the next telephone appointment will be at day 7 of the trial. After inclusion in the study, it is at the discretion of the treating GP to re-assess each participant at the general practice, when and as often as clinically needed. Physical examinations, lab testing, performing X-rays e.
In case participants are not reached at the first call, follow-up phone calls will be performed several times and participants will be sent reminders by email. Study schedule. To be able to detect an MCID of 1. Due to the fact that the number of recruited patients per GP is limited to 10, ICC might remain small. Sample size estimation was based on the assumption that individual LCQ scores are normally distributed.
Raj et al. A recent trial with a design and study population similar to ours reported a SD of 2. We decided to use the more conservative assumption of 3. A less conservative choice of an SD of 2. To compute the t test, the current version of the R language and environment R Foundation, www.
In case of recruitment difficulties due to scheduled numbers of participants not being reached at predefined milestones, the limit of maximum of 10 randomized patients per GP can be increased.
People cough for lots of reasons. One of them is irritated and swollen airways(bronchitis or asthma). Prednisone reduces swelling, so if that is why you are. A dose of 40 mg of prednisone will ensure sufficient pharmacokinetic activity to be able to reveal a potential treatment effect in post-. By 3 a.m. I was awake and coughing my head off. Corticosteroids can have many side effects that can range from mild to serious. A dose of 40 mg of prednisone will ensure sufficient pharmacokinetic activity to be able to reveal a potential treatment effect in post-. Patients with a history of prolonged cough after upper respiratory infections with no evidence of asthma may improve dramatically with the use. Certainly, some patients feel the unpleasant effects. PLoS One. If performed, the GP will also record diagnostic test results such as CRP test, white blood cell count, body temperature, blood pressure, pulse, oxygen saturation, previous or present X-Ray, previous or present lung function assessments. For clinical inquiries, we cannot provide medical advice via a public blog forum, due to privacy laws.Blog , Health , Pulmonary-Respiratory , telehealth , telemedicine 60 comments. Coughing sucks! Nothing attracts more attention than a cough. It comes in so many flavors - wet, dry, green, yellow, hacking, tightness, wheezing, productive, barking, and so on. What exactly is bronchitis? Simply, inflammation of the bronchial airways.
It can be caused by viruses, bacteria, allergies, asthma, environmental exposures, and more. Antibiotics are NOT always the best treatment for bronchitis. True, some folks swear by the trusty old "Z-pack" -- that 5 day course of antibiotics that seems, for some, to "knock it out". In reality, antibiotics usually don't help bronchitis. So how do you know if it's a bacteria, virus, or something else? Sometimes it is tough to tell the difference. You can enter all of your symptoms into your favorite internet search engine and perhaps get an idea.
However, diagnosing and treating bronchitis is something that should probably be left to a physician. Especially if you are wondering whether or not you need a prescription. That mucus that drains down the back of your throat and builds up in your chest is more likely to move up and out of your chest and sinuses when you are a hydrated. The less you drink, the more stubborn your phlegm gets. It becomes more like velcro stuck to your throat thus the sore throat and more likely to harbor nasty bacteria and worsen your condition.
This will keep the mucus from settling in the back of your throat and causing you to cough all night. Mucinex, Robitussin , plain or with the "DM" may be worth a try.
These are essentially expectorants that work best when combined with plenty of water. Acetaminophen Tylenol and ibuprofen Advil, Motrin will help with the fever, aches, and pains. The warm steam and humidity from soups, teas, showers, and the like all lessen those sensitive airways with tend to be more reactive in cold and dry environments i.
ProAir, Ventolin. If you happen to have asthma, chronic bronchitis, or COPD, then you likely have some albuterol around either in the handheld inhaler form or as a solution for the nebulizer. This bronchodilater helps with bronchospasm which is what often causes the cough of bronchitis.
If you wheeze when you cough or breath out fast, you likely have bronchospasm and you would benefit from an inhaler. Your physician can prescribe an inhaler if needed. Ok, most doctors would say these should ONLY be taken as prescribed by your doctor. These steroids are pure anti-inflammatories, used for just about any inflammatory condition known to man.
Of course, prednisone does come with several precautions: elevates blood sugar careful if you are diabetic , makes one moody or "amped up", may increase weight temporarily due to water retention, and they are not to be abruptly stopped if taking for more than days thus the day burst.
Often used second line, steroids can get a person with persistent cough and bronchitis over the hump. Chest pain with exertion that is pressure-like may indicate a more serious condition and would need to be evaluated.
Color of sputum doesn't necessarily correlate with bacterial, viral or other causes of bronchitis. This is by no means a stead and fast rule. Sputum or phlegm color and consistency is only one factor doctors use to determine how best to treat cough and bronchitis. Not sure what to do? Maybe you are experiencing some of the "red flags" described above or you are basically at your wits end?
Since your CirrusMED physician already knows your medical history, he or she can easily evaluate your case and if needed, prescribe the appropriate treatment.
All of this can be done from the convenience of your home. All you need is an internet connection. If you are on the road for the holidays or can't miss work, your CirrusMED physician will work with you so you can save time and money with "Your doctor. While most asthmatics would probably do fine taking ibuprofen, it is generally advised to take an alternative medicine for pain or bronchial inflammation— such as inhaled or oral steroids.
Have bronchitis and been on antibiotics for 4 days with little relief using a neti pot drinking Gatorade very tired missed 3 days of work will a steroid help? Unfortunately we cannot provide specific medical advice especially in a public forum , without a consultation. Please check out our membership options.
Thank you! Last fall, coughing started with excessive mucus especially at night when trying to sleep. My Dr. Tried everything that would treat allergies and asthma. Nothing worked. Finally he put me on prednisone for 2 weeks. It did the trick. Unfortunately the symptoms are returning. Dont want to go back on prednisone again Is there anything out there that I can get over the counter that would be a second best to prednisone? I think this lasting cough, after 2 rounds of antibiotics and prednisone might be Pertussis….
I feel ok between coughing fits tho. Every time I inhale deeply, I cough. Ty- Mike. For clinical inquiries, we cannot provide medical advice via a public blog forum, due to privacy laws. For those seeking specific clinical advice, we recommend establishing care with one of our doctors. Yes prednisone helps alot but do not stay on it long generally drs give 20mg for 5 days. It helps open your airway.
Im on prednisone and doc for bronchitis and drinking lots of warm water n tea. Its helping contact a dr before it gets worse. Hi doctor , my husband Yuri is 1 70 , on for high blood medication, had cronic sinus,65 day ago he started fever Have you had problems? I have been coughing for 2 months. After a while my mouth became raw. I found flavored water added 7 Halls cough drops.
It stop my coughing immediately for maybe 20 minutes. Yes but you should also ask Dr for an antibiotic or take a sinus relief medication. Mucinex helps alot but also using Vicks rub can help.
That being said, yes, steroids will reduce inflammation associated with bronchitis. NSAIDs, are not quite as effective, nor are they typically used for bronchitis inflammation. CirrusMED physicians are able to address your concerns. I had an episode of acute bronchitis over Christmas. I began to wheeze and begged my doctor for and inhaler. He prescribed Albuterol and Methylprednisolone step down.
Just coughing the junk up. So yes it does decrease the wheezing caused by acute bronchitis. Follow up re medrol pack for wheezing or will NSAIDs work for wheezing associated with acute bronchitis. Hi There! I am currently battling bacterial bronchitis as determined by my family doctor. I have 2 days left of prednisone and a z-pak. I was sick for about 12 days before I started getting a low grade fever and feeling very tired, the coughing got worse etc.
I am starting to feel much better but my cough just will not stop. In addition to the meds above I have been using cough syrup an OTC Robitussen which is just a suppressant as well as a prescribed expectorant with Codine in it. The otc cough syrup works better than the prescription at easing my cough but it is still almost unbearable. For 2 nights in a row I have had a 2 hour coughing fit where i start throwing up. I have been steaming, using cough drops….
Is there anything else I can try or ask my doctor to prescribe for me? I am willing to try anything at this point. I gave had many drs tell me how bad prednisone is for me. I have had 3 short courses last year and 1 this year.
One dr would NOT prescribe, told me it would kill me.. I have chronic cough. Would lije to kniw how bad for me I am 70 years old.. Dorthe, Unfortunately we cannot provide specific medical advice especially in a public forum , without a consultation.

Comments
Post a Comment